While GLP-1 clearly affects appetite centers in the brain, adding GIP agonism might influence different neural circuits related to food reward, energy expenditure, or metabolic regulation
So, a GLP-1 medication may be helpful as an adjunct in patients who meet criteria for obesity treatment, but patients shouldn't expect it to independently induce remission, I would say
Research-Grade Peptides It is critical to source CJC-1295 and Ipamorelin only through a licensed healthcare provider and an accredited compounding pharmacy
Additionally, some research suggests potential impacts on tissue aging at a cellular level, possibly involving stem cells
GLP-1 Weight Loss Statistics 2026: Semaglutide & Tirzepatide Data, Market Size & Obesity Trends GLP-1 Weight Loss Statistics 2026: Semaglutide & Tirzepatide Data, Market Size & Obesity Trends The most comprehensive GLP-1 statistics resource for 2026